12.06.2015 09:15:08
|
DSM - repurchase of shares (5 June - 11 June 2015)
Royal DSM, the global Life Sciences and Materials Sciences company, has repurchased 185,315 of its own shares in the period from 5 June 2015 up to and including 11 June 2015 at an average price of €53.36. This is in accordance with the repurchase, covering existing option plans, announced on 14 May 2015. The consideration of this repurchase was €9.9 million.
The total number of shares repurchased under this program to date is 815,313 shares for a total consideration of €43.7 million.
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
For more information:
DSM Corporate Communications Herman Betten tel. +31 (0) 45 5782017 e-mail media.contacts@dsm.com | DSM Investor Relations Dave Huizing tel. +31 (0) 45 5782864 e-mail investor.relations@dsm.com |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DSM NVmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu DSM NVmehr Analysen
Aktien in diesem Artikel
DSM NV | 108,95 | -0,86% |
|